PRIMECAP MANAGEMENT CO/CA/ – Zentalis Pharmaceuticals, Inc. Transaction History
PRIMECAP MANAGEMENT CO/CA/ portfolio value:
$25.55M
portfolio value
PRIMECAP MANAGEMENT CO/CA/ quarter portfolio value change:
-22.92%
quarter
Zentalis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.03% | -12.3K shares | -7.94M | $21.66 | 1.17M |
| Q2 2022 | share | Decrease | -1.37% | -16.59K shares | -22.26M | $28.1 | 1.19M |
| Q1 2022 | share | Decrease | -3.59% | -45.05K shares | -49.61M | $46.14 | 1.20M |
| Q4 2021 | share | Decrease | -6.14% | -81.98K shares | 16.37M | $82.68 | 1.25M |
| Q3 2021 | share | Decrease | -0.96% | -12.99K shares | 17.26M | $66.64 | 1.33M |
| Q2 2021 | share | Increase | +0.99% | 13.18K shares | 13.80M | $53.2 | 1.34M |
| Q1 2021 | share | Decrease | -2.64% | -36.26K shares | -13.30M | $43.39 | 1.33M |
| Q4 2020 | share | Decrease | -0.80% | -11.06K shares | 26.04M | $51.94 | 1.37M |
| Q3 2020 | share | Increase | +109.52% | 722.8K shares | 13.51M | $32.69 | 1.38M |
| Q2 2020 | share | Increase | 0.00% | 659.95K shares | 31.69M | $48.02 | 659.95K |